Title:
NOVEL SULFONAMIDE MENIN-MLL INTERACTION INHIBITOR, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/011446
Kind Code:
A1
Abstract:
Provided are a compound of formula (I), a pharmaceutically acceptable salt thereof, and a preparation method therefor and a use thereof. The compound can be used a drug in the treatment of diseases and disorders comprising cancer, and other diseases mediated by menin-MLL interaction.
Inventors:
ZHU HUI (CN)
WANG JIANHANG (CN)
ZHAO JIEBIN (CN)
WU XIANQIANG (CN)
CHEN HONG (CN)
WANG YING (CN)
WANG JIANHANG (CN)
ZHAO JIEBIN (CN)
WU XIANQIANG (CN)
CHEN HONG (CN)
WANG YING (CN)
Application Number:
PCT/CN2022/109631
Publication Date:
February 09, 2023
Filing Date:
August 02, 2022
Export Citation:
Assignee:
CHENGDU EASTON BIOPHARMACEUTICALS CO LTD (CN)
International Classes:
C07D405/14; A61K31/407; A61P3/10; A61P35/00; C07D403/04; C07D403/14; C07D471/10; C07D487/10; C07D491/10
Domestic Patent References:
| WO2014164543A1 | 2014-10-09 | |||
| WO2015191701A1 | 2015-12-17 |
Foreign References:
| CN109743875A | 2019-05-10 | |||
| CN107922378A | 2018-04-17 | |||
| CN109152784A | 2019-01-04 |
Download PDF: